{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T13:40:55Z","timestamp":1763041255118,"version":"3.45.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"vor","delay-in-days":2404,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["intpsychogeriatrics.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Psychogeriatrics"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1017\/s1041610217003015","type":"journal-article","created":{"date-parts":[[2018,1,30]],"date-time":"2018-01-30T05:04:01Z","timestamp":1517288641000},"page":"833-841","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["A pharmacopsychometric overview of major depressive episodes in positive psychiatry"],"prefix":"10.1016","volume":"30","author":[{"given":"P.","family":"Bech","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myrra","family":"Vernooij-Dassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esme","family":"Moniz-Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Hee","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1017\/S1041610217003015_bb0010","doi-asserted-by":"crossref","first-page":"e0170000","DOI":"10.1371\/journal.pone.0170000","article-title":"The major depressive disorder hierarchy: Rasch analysis of 6 items of the Hamilton depression scale covering the continuum of depressive syndrome","volume":"12","author":"Alves","year":"2017","journal-title":"Plos One"},{"year":"2013","series-title":"Diagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM-5)","author":"American Psychiatric Association","key":"10.1017\/S1041610217003015_bb0015"},{"key":"10.1017\/S1041610217003015_bb0020","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/BF00407438","article-title":"A clinical analysis of the effects of tofranil in depression. Longitudinal and follow-up studies. Treatment of blood-relations","volume":"2","author":"Angst","year":"1961","journal-title":"Psychopharmacologia"},{"key":"10.1017\/S1041610217003015_bb0025","first-page":"287","article-title":"The myths of psychopharmacology","author":"Angst","year":"1996"},{"key":"10.1017\/S1041610217003015_bb0030","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1055\/s-0028-1094453","article-title":"Mental illness and simulated driving: before and during treatment","volume":"8","author":"Bech","year":"1975","journal-title":"Pharmakopsychiatrie Neuro-Psychopharmakologie"},{"year":"1993","series-title":"Rating Scales for Psychopathology, Health Status and Quality of Life. A Compendium on Documentation in Accordance with the DSM-III-R and WHO Systems","author":"Bech","key":"10.1017\/S1041610217003015_bb0035"},{"year":"1998","series-title":"Quality of Life in the Psychiatric Patient","author":"Bech","key":"10.1017\/S1041610217003015_bb0040"},{"key":"10.1017\/S1041610217003015_bb0045","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1034\/j.1399-6576.1999.430906.x","article-title":"Health-related quality of life measurements in the assessment of pain clinic results","volume":"43","author":"Bech","year":"1999","journal-title":"Acta Anaesthesiologica Scandinavica"},{"year":"2012","series-title":"Clinical Psychometrics","author":"Bech","key":"10.1017\/S1041610217003015_bb0050"},{"key":"10.1017\/S1041610217003015_bb0055","first-page":"127","article-title":"Clinical assessments of positive mental health","author":"Jeste","year":"2015"},{"year":"2016","series-title":"Measurement-Based Care in Mental Disorders","author":"Bech","key":"10.1017\/S1041610217003015_bb0060"},{"key":"10.1017\/S1041610217003015_bb0065","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1600-0447.1981.tb00676.x","article-title":"The Hamilton depression scale. Evaluation of objectivity using logistic models","volume":"63","author":"Bech","year":"1981","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1017\/S1041610217003015_bb0070","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1600-0447.1975.tb00002.x","article-title":"Quantitative rating of depressive states","volume":"51","author":"Bech","year":"1975","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1017\/S1041610217003015_bb0075","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/YIC.0b013e32830cebed","article-title":"Efficacy, safety, and tolerability of fixed-dose desvenlafaxine 50 and 100 mg\/day for major depressive disorder in a placebo-controlled trial","volume":"23","author":"Boyer","year":"2008","journal-title":"International Clinical Psychopharmacology"},{"year":"2013","series-title":"The Placebo Effect in Clinical Practice","author":"Brown","key":"10.1017\/S1041610217003015_bb0080"},{"key":"10.1017\/S1041610217003015_bb0085","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1055\/s-0034-1398509","article-title":"Driving performance and psychomotor function in depressed patients treated with agomelatine or venlafaxine","volume":"48","author":"Brunnauer","year":"2015","journal-title":"Pharmacopsychiatry"},{"key":"10.1017\/S1041610217003015_bb0090","doi-asserted-by":"crossref","first-page":"g1626","DOI":"10.1136\/bmj.g1626","article-title":"Serotonin syndrome","volume":"348","author":"Buckley","year":"2014","journal-title":"BMJ"},{"key":"10.1017\/S1041610217003015_bb0095","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1017\/S0033291709006114","article-title":"The effects of psychotherapy for adult depression are overestimated: a meta-analysis of study quality and effect size","volume":"40","author":"Cuijpers","year":"2010","journal-title":"Psychological Medicine"},{"key":"10.1017\/S1041610217003015_bb0100","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0165-0327(90)90081-I","article-title":"Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group","volume":"18","author":"DUAG","year":"1990","journal-title":"Journal of Affective Disorders"},{"key":"10.1017\/S1041610217003015_bb0105","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0009-9236(99)90053-X","article-title":"Clomipramine dose-effect study in patients with depression: clinical end points and pharmacokinetics. Danish University Antidepressant Group (DUAG)","volume":"66","author":"DUAG","year":"1999","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1017\/S1041610217003015_bb0110","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1001\/archpsyc.1989.01810110013002","article-title":"National institute of mental health treatment of depression collaborative research program. General effectiveness of treatments","volume":"46","author":"Elkin","year":"1989","journal-title":"Archives of General Psychiatry"},{"key":"10.1017\/S1041610217003015_bb0115","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1037\/0022-006X.64.1.92","article-title":"Science is not a trial (but it can sometimes be a tribulation)","volume":"64","author":"Elkin","year":"1996","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"10.1017\/S1041610217003015_bb0120","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000438946","article-title":"The relationship between sleep length and restorative sleep in major depression: results from the Danish general suburban population study","volume":"85","author":"Ellervik","year":"2016","journal-title":"Psychother Psychosom"},{"key":"10.1017\/S1041610217003015_bb0125","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3109\/08039488.2013.877074","article-title":"Prevalence of depression, quality of life and antidepressant treatment in the Danish general suburban population study","volume":"68","author":"Ellervik","year":"2014","journal-title":"Nordic Journal of Psychiatry"},{"key":"10.1017\/S1041610217003015_bb0130","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000458458","article-title":"Clinical pharmacopsychology: conceptual foundations and emerging tasks","volume":"86","author":"Fava","year":"2017","journal-title":"Psychotherapy and Psychosomatics"},{"year":"1987","series-title":"Clinometric","author":"Feinstein","key":"10.1017\/S1041610217003015_bb0135"},{"key":"10.1017\/S1041610217003015_bb0140","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1001\/jama.1994.03520080061045","article-title":"A critical appraisal of the quality of quality-of-life measurements","volume":"272","author":"Gill","year":"1994","journal-title":"JAMA"},{"key":"10.1017\/S1041610217003015_bb0145","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1176\/appi.ajp.2015.15040476","article-title":"The sequential integration of pharmacotherapy and psychotherapy in the treatment of major depressive disorder: a meta-analysis of the sequential model and a critical review of the literature","volume":"173","author":"Guidi","year":"2016","journal-title":"The American Journal of Psychiatry"},{"key":"10.1017\/S1041610217003015_bb0150","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1037\/a0023054","article-title":"Examining functional content in widely used health-related quality of life scales","volume":"56","author":"Rehabilitation Research and Training Center Expert Panel on Health Measurement","year":"2011","journal-title":"Rehabilitation Psychology"},{"key":"10.1017\/S1041610217003015_bb0155","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1017\/S1041610217003015_bb0160","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.2044-8260.1967.tb00530.x","article-title":"Development of a rating scale for primary depressive illness","volume":"6","author":"Hamilton","year":"1967","journal-title":"The British Journal of Social and Clinical Psychology"},{"key":"10.1017\/S1041610217003015_bb0165","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.4088\/JCP.14r09528","article-title":"Response of depression to electroconvulsive therapy: a meta-analysis of clinical predictors","volume":"76","author":"Haq","year":"2015","journal-title":"The Journal of Clinical Psychiatry"},{"year":"2009","series-title":"Visible Learning. A Synthesis of Over 800 Meta-Analyses Relating to Achievement","author":"Hattie","key":"10.1017\/S1041610217003015_bb0170"},{"key":"10.1017\/S1041610217003015_bb0175","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1001\/archpsyc.1995.03950130011002","article-title":"Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses","volume":"52","author":"Hays","year":"1995","journal-title":"Archives of General Psychiatry"},{"key":"10.1017\/S1041610217003015_bb0180","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1001\/archpsyc.56.5.431","article-title":"Treatment of atypical depression with cognitive therapy or phenelzine","volume":"56","author":"Jarrett","year":"1999","journal-title":"Archives of General Psychiatry"},{"key":"10.1017\/S1041610217003015_bb0185","doi-asserted-by":"crossref","first-page":"675","DOI":"10.4088\/JCP.14nr09599","article-title":"Positive psychiatry: its time has come","volume":"76","author":"Jeste","year":"2015","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1017\/S1041610217003015_bb0190","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S0140-6736(80)92393-4","article-title":"The Northwick Park electroconvulsive therapy trial","volume":"2","author":"Johnstone","year":"1980","journal-title":"Lancet"},{"year":"1968","series-title":"The Classification of Depressive Illnesses","author":"Kendell","key":"10.1017\/S1041610217003015_bb0195"},{"key":"10.1017\/S1041610217003015_bb0200","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1192\/bjp.139.4.265","article-title":"The present status of electroconvulsive therapy","volume":"139","author":"Kendell","year":"1981","journal-title":"The British Journal of Psychiatry: The Journal of Mental Science"},{"year":"1913","series-title":"Psychiatrie. Bind 3","author":"Kraepelin","key":"10.1017\/S1041610217003015_bb0205"},{"year":"2016","series-title":"Ordinarily Well. The Case for Antidepressants","author":"Kramer","key":"10.1017\/S1041610217003015_bb0210"},{"issue":"Suppl. 44","key":"10.1017\/S1041610217003015_bb0215","first-page":"5","article-title":"Patient-rated versus clinician-rated side effects of drug treatment in schizophrenia.Clinical validation of a self-rating version of the UKU side effect rating scale (UKU-SERS-Pat)","volume":"55","author":"Lindstrom","year":"2001","journal-title":"Nordic Journal of Psychiatry"},{"key":"10.1017\/S1041610217003015_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0447.1987.tb10566.x","article-title":"The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients","volume":"334","author":"Lingjaerde","year":"1987","journal-title":"Acta Psychiatrica Scandinavica Supplementum"},{"key":"10.1017\/S1041610217003015_bb0225","doi-asserted-by":"crossref","first-page":"171857","DOI":"10.1155\/2012\/171857","article-title":"The validity of the WHO-5 as an early screening for apathy in an elderly population","volume":"2012","author":"Lucas-Carrasco","year":"2012","journal-title":"Current Gerontology and Geriatrics Research"},{"issue":"Suppl. 35","key":"10.1017\/S1041610217003015_bb0230","first-page":"1","article-title":"Prognosis and course in manic-depressive psychosis","author":"Lundquist","year":"1945","journal-title":"Acta Psychiatrica et Neurologica Scandinavica"},{"year":"2008","series-title":"The Global Burden of Disease: 2004 Update","author":"World Health Organization","key":"10.1017\/S1041610217003015_bb0235"},{"key":"10.1017\/S1041610217003015_bb0240","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/bmj.1.5439.881","article-title":"Clinical trial of the treatment of depressive illness: report to the medical research council by its clinical psychiatry committee","volume":"1","author":"Medical Research Council","year":"1965","journal-title":"The British Medical Journal"},{"key":"10.1017\/S1041610217003015_bb0245","first-page":"261","article-title":"Biology of positive psychiatry","author":"Jeste","year":"2015"},{"issue":"Suppl. 181","key":"10.1017\/S1041610217003015_bb0250","first-page":"1","article-title":"On relation between clinical factors and efficacy of ECT in depression","volume":"40","author":"Nystr\u00f6m","year":"1964","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1017\/S1041610217003015_bb0255","first-page":"5","article-title":"Experimental studies of the mode of action of electroconvulsive therapy","volume":"35","author":"Ottosson","year":"1960","journal-title":"Acta Psychiatrica et Neurologica Scandinavica"},{"key":"10.1017\/S1041610217003015_bb0260","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/0006-3223(85)90190-8","article-title":"Use and misuse of electroconvulsive treatment","volume":"20","author":"Ottosson","year":"1985","journal-title":"Biological Psychiatry"},{"year":"1980","series-title":"Probablistic Models for Some Intelligence and Attainment Tests","author":"Rasch","key":"10.1017\/S1041610217003015_bb0265"},{"key":"10.1017\/S1041610217003015_bb0270","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0165-0327(94)00101-E","article-title":"Clinical characteristics of outpatients with chronic major depression","volume":"34","author":"Rush","year":"1995","journal-title":"Journal of Affective Disorders"},{"key":"10.1017\/S1041610217003015_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ijnp\/pyv076","article-title":"Prevention of relapse and recurrence in adults with major depressive disorder: systematic review and meta-analyses of controlled trials","volume":"19","author":"Sim","year":"2016","journal-title":"The International Journal of Neuropsychopharmacology"},{"key":"10.1017\/S1041610217003015_bb0280","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000457131","article-title":"A systematic review of the clinometric properties of the 6-item version of the Hamilton depression rating scale (HAM-D6)","volume":"86","author":"Timmerby","year":"2017","journal-title":"Psychother Psychosom"},{"key":"10.1017\/S1041610217003015_bb0285","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000376585","article-title":"The WHO-5 well-being index: a systematic review of the literature","volume":"84","author":"Topp","year":"2015","journal-title":"Psychotherapy and Psychosomatics"},{"key":"10.1017\/S1041610217003015_bb0290","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0140-6736(03)12705-5","article-title":"Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis","volume":"361","author":"UK ECT Review Group","year":"2003","journal-title":"Lancet"},{"key":"10.1017\/S1041610217003015_bb0295","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1177\/0269881106061101","article-title":"Acute and subchronic effects of amitriptyline 25 mg on actual driving in chronic neuropathic pain patients","volume":"20","author":"Veldhuijzen","year":"2006","journal-title":"Journal of Psychopharmacology"},{"key":"10.1017\/S1041610217003015_bb0300","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00131746-200603000-00002","article-title":"Self-rated global measure of the frequency, intensity, and burden of side effects","volume":"12","author":"STARD Investigators","year":"2006","journal-title":"Journal of Psychiatric Practice"},{"year":"1992","series-title":"International Classification of Disease. Tenth Revision (ICD-10).Clinical Description and Diagnostic Guidelines","author":"World Health Organization","key":"10.1017\/S1041610217003015_bb0305"}],"container-title":["International Psychogeriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224016855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610224016855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1041610217003015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T13:35:15Z","timestamp":1763040915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1041610224016855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":60,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S1041610224016855"],"URL":"https:\/\/doi.org\/10.1017\/s1041610217003015","relation":{},"ISSN":["1041-6102"],"issn-type":[{"type":"print","value":"1041-6102"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A pharmacopsychometric overview of major depressive episodes in positive psychiatry","name":"articletitle","label":"Article Title"},{"value":"International Psychogeriatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1017\/S1041610217003015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 International Psychogeriatric Association. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}